Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men-Reference-Cited by-同舟云学术

Early stage development of the glycine-1 re-uptake inhibitor SCH 900435: central nervous system effects compared with placebo in healthy men

Published:2013-05-20 Issue:6 Volume:75 Page:1455-1467
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Liem-Moolenaar Marieke¹,Peeters Pierre²,Kamerling Ingrid M. C.¹,Hogg Chris,Holder Graham,Kleijn Huub Jan²,Spaans Edwin²,Udo De Haes Joanna²,de Kam Marieke L.¹,Franson Kari L.¹,Cohen Adam F.¹,van Gerven Joop M. A.¹

Affiliation:

1. Centre for Human Drug Research; Zernikedreef 10; Leiden

2. MSD; Early Stage Development; Molenstraat 110; Oss; the Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12015/fullpdf

Reference45 articles.

1. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs;Creese;Science,1976

2. Brain receptors for antipsychotic drugs and dopamine: direct binding assays;Seeman;Proc Natl Acad Sci USA,1975

3. Is the glycine site half saturated or half unsaturated? Effects of glutamatergic drugs in schizophrenia patients;Javitt;Curr Opin Psychiatry,2006

4. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses;Krystal;Arch Gen Psychiatry,1994

5. Recent advances in the phencyclidine model of schizophrenia;Javitt;Am J Psychiatry,1991

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer’s dementia: a randomized controlled trial;Alzheimer's Research & Therapy;2023-01-28

2. An Overview of Glycine Transporter Subtype 1 Inhibitors Under Preclinical and Clinical Evaluation for the Treatment of Alcohol Abuse;Current Psychiatry Research and Reviews;2022-03

3. Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset;European Journal of Pharmacology;2021-11

4. Multiple Rising Doses of Oral BI 425809, a GlyT1 Inhibitor, in Young and Elderly Healthy Volunteers: A Randomised, Double-Blind, Phase I Study Investigating Safety and Pharmacokinetics;Clinical Drug Investigation;2018-05-30

5. Medications for alcohol use disorders: An overview;Pharmacology & Therapeutics;2018-05